Shringar House of Mangalsutra IPO GMP, Price Band, Dates & Subscription Details

When it comes to IPOs, few generate as much curiosity as those in the jewelry space. The Shringar House of Mangalsutra IPO GMP has been trending lately, reflecting the excitement among investors. If you’re wondering what makes this issue special and whether it’s worth applying for, let’s walk through the details in plain language.

About Shringar House of Mangalsutra

Shringar House of Mangalsutra Ltd., based in Mumbai, has carved out a niche by focusing exclusively on mangalsutras. For those unfamiliar, a mangalsutra is not just jewelry but a culturally significant ornament in Indian marriages. Shringar specializes in designing and manufacturing these pieces in 18k and 22k gold, often set with stones like pearls, cubic zirconia, and American diamonds

The company has more than 10,000 SKUs and serves some of the biggest names in retail—Titan, Malabar Gold, Reliance Retail, and Joyalukkas, to name a few. It operates across 24 Indian states and has expanded internationally into markets such as the UAE, USA, and UK.

IPO Details at a Glance

• Issue Size: ₹401 crore (entirely fresh issue of 2.43 crore shares)
  
• Price Band: ₹155–₹165 per share
  
• Lot Size: Minimum 90 shares (₹14,850 at the upper band)
  
• Bidding Dates: September 10–12, 2025
  
• Listing Date: September 17, 2025, on BSE and NSE
  
• Use of Funds: Primarily for working capital and general corporate purposes
  

The company has already secured ₹120 crore from anchor investors ahead of the IPO, which signals institutional confidence.

Shringar House of Mangalsutra IPO GMP Trend

This is where investor excitement is most visible. The Shringar House of Mangalsutra IPO GMP has been hovering in the ₹25–31 range:

• On September 9, GMP stood at around ₹25, hinting at a listing price of ₹190.
  
• On September 10, the first day of the IPO, it climbed to ₹30–31, pointing to a listing around ₹195–196
  

This translates to an expected 15–18% premium over the issue price. While GMP isn’t official or guaranteed, it often mirrors market sentiment ahead of listing.

Financial Highlights

Shringar’s growth story looks promising:

• Revenue jumped from ₹1,101.5 crore in FY23 to ₹1,429.8 crore in FY25, a ~30% rise.
  
• Net profit nearly doubled from ₹31.1 crore in FY23 to ₹61.1 crore in FY25.
  
• Margins improved too, with PAT margin at 4.27% in FY25.
  
• Return on capital employed (ROCE) reached a healthy 32.4%.
  

These numbers put the IPO’s valuation at about 19–26x earnings, which analysts say is fair to slightly premium compared to jewelry peers

Risks You Should Know

No IPO is without risks, and it’s worth noting a few:

• The company depends heavily on a single product (mangalsutras).
  
• All manufacturing happens in a single Mumbai facility, which makes operations vulnerable to disruptions.
  
• Nearly half its revenue comes from Maharashtra, showing regional concentration risk.
  
• Jewelry demand is seasonal and sensitive to gold price fluctuations
  

Should You Subscribe?

Brokerages like Anand Rathi and Master Capital have given a “Subscribe” rating for medium to long-term investors. The reasons are simple: strong financials, a focused niche, and rising demand for organized jewelry brands.

That said, if you’re looking for quick listing gains, the Shringar House of Mangalsutra IPO GMP indicates a healthy premium in the grey market. But remember—GMP is unofficial, and actual listing performance can differ.

Final Thoughts

The Shringar House of Mangalsutra IPO GMP suggests strong market enthusiasm, with investors expecting up to an 18% listing pop. The company’s growth numbers and marquee client base add weight to the optimism.

For long-term investors, this IPO could be a way to tap into India’s cultural jewelry market with a specialized player. For short-term traders, the GMP trend looks promising, but it’s wise to balance the hype with fundamentals.

Check our other Articles.